Profile
Ashley Ivor Simon Morris served as the Area Director at PT Organon Pharma Indonesia Tbk from 2004 to 2009.
In 2017, he briefly served as the Chief Executive Officer & Executive Director at SciGen Pte Ltd.
Morris obtained his undergraduate degree from The University of Nottingham in 2013.
Former positions of Ashley Ivor Simon Morris
Companies | Position | End |
---|---|---|
SCIGEN LIMITED | Chief Executive Officer | 07/09/2017 |
MERCK SHARP DOHME PHARMA TBK PT | Corporate Officer/Principal | 31/12/2008 |
Training of Ashley Ivor Simon Morris
The University of Nottingham | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MERCK SHARP DOHME PHARMA TBK PT | Health Technology |
Private companies | 1 |
---|---|
SciGen Pte Ltd.
SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore. | Health Technology |
- Stock Market
- Insiders
- Ashley Ivor Simon Morris